Valuation: Optiscan Imaging Limited

Market Cap 125M 86.95M 76.15M 70.14M 65.1M 124M 8.29B 840M 327M 4.07B 327M 319M 14.12B P/E 2024
-31.8x
P/E 2025 -14.5x
Enterprise Value 122M 84.82M 74.28M 68.42M 63.51M 121M 8.09B 819M 319M 3.97B 319M 312M 13.77B EV / Sales 2024
62.1x
EV / Sales 2025 23.8x
Free-Float
36.32%
Yield 2024 *
-
Yield 2025 -
1 day+11.11%
1 week+25.00%
Current month+25.00%
1 month+11.11%
3 months+53.06%
6 months+61.29%
Current year+50.00%
1 week 0.12
Extreme 0.125
0.16
1 month 0.12
Extreme 0.12
0.16
Current year 0.08
Extreme 0.08
0.16
1 year 0.08
Extreme 0.079
0.16
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.29
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 2021-12-12
Director of Finance/CFO - 2025-03-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2021-04-18
Director/Board Member - 2022-06-13
Director/Board Member - 2021-07-28
Date Insider Type Main position Quantity % Market Cap.
05-21Sell

Director

-3,000,000 0.2873%
01-14Free

Director

230,502 0.0221%
01-14Free

Chairman

419,094 0.0401%
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%+25.00%+36.36%+70.45% 97.82M
+1.73%+4.63%-15.56%-25.12% 12.88B
-7.35%-1.37%+82.27%+7.20% 4.81B
+1.32%+8.75%+65.53%+123.80% 1.31B
+0.26%+7.10%-30.89%-61.52% 1.24B
-1.20%+3.78%-37.82%-46.83% 1.11B
-1.22%+2.90%-43.88% - 916M
+4.10%-3.10%+177.18%+161.29% 662M
-9.20%-12.33%+50.23% - 330M
-1.87%-11.06%-53.77%+219.66% 257M
Average -0.23%+1.61%+22.97%+56.12% 2.36B
Weighted average by Cap. -0.56%+1.91%+12.03%-3.81%

Financials

2024 2025
Net sales 2.99M 2.07M 1.81M 1.67M 1.55M 2.95M 198M 20.01M 7.79M 97.02M 7.78M 7.61M 336M 3.72M 2.58M 2.26M 2.08M 1.94M 3.67M 247M 24.95M 9.71M 121M 9.71M 9.49M 420M
Net income -6.06M -4.21M -3.68M -3.39M -3.15M -5.98M -401M -40.61M -15.8M -197M -15.79M -15.45M -683M -6.31M -4.38M -3.84M -3.53M -3.28M -6.23M -418M -42.29M -16.46M -205M -16.45M -16.09M -711M
Net Debt -11.01M -7.64M -6.69M -6.16M -5.72M -10.86M -729M -73.78M -28.71M -358M -28.69M -28.06M -1.24B -3.07M -2.13M -1.87M -1.72M -1.6M -3.03M -203M -20.58M -8.01M -99.77M -8M -7.83M -346M
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
26-07-07 A$0.1500 +11.11% 991,062
26-07-06 A$0.1350 0.00% 285,100
26-07-03 A$0.1350 0.00% 819,405
26-07-02 A$0.1350 +8.00% 367,400
26-07-01 A$0.1250 +4.17% 150,269